Down 18.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Banco Macro (BMA) — Positive
BMA Zacks Investment Research — June 10, 2025The heavy selling pressure might have exhausted for Banco Macro (BMA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

July 14, 2025 Deadline: Join Class Action Lawsuit Against Iovance Biotherapeutics, Inc. (IOVA) - Contact Levi & Korsinsky — Neutral
IOVA Accesswire — June 10, 2025NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=152439&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.

July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky — Neutral
WST Accesswire — June 10, 2025NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152437&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.

Class Action Lawsuit Filed Against Krispy Kreme, Inc. (DNUT) - Recover Losses - Contact Levi & Korsinsky Before July 15, 2025 — Neutral
DNUT Accesswire — June 10, 2025NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=152436&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq.

Redburn Atlantic earlier downgraded the shares of blue-chip fast food giant McDonald's Corp (NYSE:MCD) to "sell" form "buy," and cut its price target to $260 from $319.

Tiger Finance Provides $35 Million in Funding for The Beachbody Co. — Neutral
BODI PRNewsWire — June 10, 2025NEW YORK, June 10, 2025 /PRNewswire/ -- Tiger Capital Group's lending platform, Tiger Finance, has provided $35 million in financing to The Beachbody Company, Inc. (NYSE:BODI), a leading fitness and nutrition company.

Arista 2.0 Strategy Gaining Traction: Is it the Next Key Growth Driver? — Positive
ANET Zacks Investment Research — June 10, 2025ANET's Arista 2.0 strategy gains momentum with AI, SaaS and new markets driving its next wave of growth.

Sezzle Stock Skyrockets 1000% in a Year: Should You Buy It Now? — Positive
SEZL Zacks Investment Research — June 10, 2025SEZL is outpacing BNPL rivals with surging revenues, leaner operations and rising analyst confidence in 2025.

Lakeland's Q1 Earnings Miss Estimates, Sales Increase Y/Y — Negative
LAKE Zacks Investment Research — June 10, 2025LAKE posts Q1 loss despite 28.7% sales growth, hit by rising costs and shrinking gross margins.

SIVR hits a 52-week high as silver surges past $36 amid supply deficits, dollar weakness and geopolitical uncertainty.

Brokers Suggest Investing in Enterprise Products (EPD): Read This Before Placing a Bet — Neutral
EPD Zacks Investment Research — June 10, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Should You Invest in Intuitive Surgical (ISRG) Based on Bullish Wall Street Views? — Positive
ISRG Zacks Investment Research — June 10, 2025When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

UroGen: Despite ODAC Vote, Hope Remains With Targeting Of Other Cancer Subpopulation — Positive
URGN Seeking Alpha — June 10, 2025PDUFA date of June 13th 2025 by which FDA will decide upon whether or not UGN-102 should be approved for patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer. The 7 major bladder cancer markets are expected to reach $5.4 billion by 2034. Company is developing anti-CTLA4 antibody UGN-301 in a phase 1 study either alone as a monotherapy or in combination to target patients with recurrent high-grade non-muscle invasive bladder cancer.

Is CleanSpark (CLSK) a Buy as Wall Street Analysts Look Optimistic? — Positive
CLSK Zacks Investment Research — June 10, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Wall Street Analysts See Dell Technologies (DELL) as a Buy: Should You Invest? — Negative
DELL Zacks Investment Research — June 10, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Brokers Suggest Investing in Affirm Holdings (AFRM): Read This Before Placing a Bet — Negative
AFRM Zacks Investment Research — June 10, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Wall Street Analysts Look Bullish on Axon (AXON): Should You Buy? — Positive
AXON Zacks Investment Research — June 10, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Should You Invest in TSMC (TSM) Based on Bullish Wall Street Views? — Positive
TSM Zacks Investment Research — June 10, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investigation Underway: Tempus AI, Inc. (TEM) - Contact Levi & Korsinsky Over Securities Law Violations — Neutral
TEM Accesswire — June 10, 2025NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tempus AI, Inc. ("Tempus AI, Inc.") (NASDAQ:TEM) concerning possible violations of federal securities laws. Spruce Point Capital Management ("Spruce Point") published a report on Tempus, on May 28, 2025, describing a number of "concerns" about the Company.

TMCI DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action - TMCI — Neutral
TMCI Accesswire — June 10, 2025NEW YORK, NY / ACCESS Newswire / June 10, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ:TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period"), of the important June 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Treace Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
